1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database

Bibliographic Details
Main Authors: Laure Thomas, Samy Babai, Axelle Histe
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1797629785226084352
author Laure Thomas
Samy Babai
Axelle Histe
author_facet Laure Thomas
Samy Babai
Axelle Histe
author_sort Laure Thomas
collection DOAJ
first_indexed 2024-03-11T10:57:54Z
format Article
id doaj.art-156bcaef0daa4311b345e1ed16d3fe78
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-11T10:57:54Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-156bcaef0daa4311b345e1ed16d3fe782023-11-12T23:55:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.12401240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance databaseLaure Thomas0Samy Babai1Axelle Histe24 Regional Pharmacovigilance Center, Henri Mondor Hospital, Créteil, FranceMondor Hospital, Creteil, FranceMondor Hospital, Creteil, France
spellingShingle Laure Thomas
Samy Babai
Axelle Histe
1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database
Journal for ImmunoTherapy of Cancer
title 1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database
title_full 1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database
title_fullStr 1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database
title_full_unstemmed 1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database
title_short 1240 Safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments: analysis of french pharmacovigilance database
title_sort 1240 safety profile of pembrolizumab monotherapy versus pembrolizumab with combined treatments analysis of french pharmacovigilance database
work_keys_str_mv AT laurethomas 1240safetyprofileofpembrolizumabmonotherapyversuspembrolizumabwithcombinedtreatmentsanalysisoffrenchpharmacovigilancedatabase
AT samybabai 1240safetyprofileofpembrolizumabmonotherapyversuspembrolizumabwithcombinedtreatmentsanalysisoffrenchpharmacovigilancedatabase
AT axellehiste 1240safetyprofileofpembrolizumabmonotherapyversuspembrolizumabwithcombinedtreatmentsanalysisoffrenchpharmacovigilancedatabase